Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × CTLA-4 Antigen × 90 days × Clear all

Sponsor

Conditions

Melanoma 9 Carcinoma, Renal Cell 6 Neoplasm Metastasis 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Penile Neoplasms 2 Myelodysplastic Syndromes 2 Meningioma 2 Carcinoma, Transitional Cell 2 Carcinoma, Endometrioid 2 Carcinoma, Basal Cell 2 Vulvar Neoplasms 1 Urachal adenocarcinoma 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Seminoma 1 Sarcoma, Kaposi 1 Rare Diseases 1 Pseudomyxoma Peritonei 1 Prostatic Neoplasms, Castration-Resistant 1 Pheochromocytoma 1

Interventions

Cyclophosphamide 21 Rituximab 18 fludarabine 15 obinutuzumab 10 pirtobrutinib 9 fludarabine phosphate 9 venetoclax 8 ibrutinib 7 Prednisone 7 Lenalidomide 7 Biopsy 7 tocilizumab 6 glofitamab 6 Specimen Handling 6 Immunotherapy, Adoptive 6 polatuzumab vedotin 5 Mycophenolic Acid 5 Magnetic Resonance Spectroscopy 5 X-Rays 4 Tacrolimus 4 Phantoms, Imaging 4 Doxorubicin 4 pembrolizumab 3 palbociclib 3 olaparib 3 axicabtagene ciloleucel 3 Whole-Body Irradiation 3 Vincristine 3 Vemurafenib 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡